Asher Biotherapeutics, Inc.
South San Francisco, US · Founded 2019 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
YA
Yik Andy YeungExecutive Officer, Director, Promoter
ID
Ivana DjureticExecutive Officer, Director, Promoter
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$55MraisedApr 2024 · 16 investors · BiotechnologyRule 506(b)
▶$55MraisedApr 2024 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig GibbsExecutive Officer, Director
- Ivana DjureticExecutive Officer, Director
- Jeffrey TongDirector
- Reid HuberDirector
- Kyle ElrodExecutive Officer
- Bob DeresiewiczDirector
- Elaine SunDirector
- Andy YeungExecutive Officer
- Don O'SullivanExecutive Officer
- Ian ClarkDirector
- Offering amount
- $55M
- Amount sold
- $55M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$108MraisedSep 2021 · 22 investors · BiotechnologyRule 506(b)
▶$108MraisedSep 2021 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yik Andy YeungExecutive Officer
- Ivana DjureticExecutive Officer, Director
- Kyle ElrodExecutive Officer
- Reid HuberDirector
- Craig GibbsExecutive Officer, Director
- Jeffrey TongDirector
- Offering amount
- $108M
- Amount sold
- $108M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$490KraisedSep 2019 · 8 investors · BiotechnologyRule 506(b)
▶$490KraisedSep 2019 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yik Andy YeungExecutive Officer, Director, Promoter
- Ivana DjureticExecutive Officer, Director, Promoter
- Offering amount
- $3M
- Amount sold
- $490K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.